26.90500 EUR
0
0%
Last update Dec 15, 8:00 AM CET
Main market
Day range
26.90500
26.90500
Previous close
26.90500
Open
26.90500
Access this stock data via API
Subscribe
TG Therapeutics, Inc.
26.91
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 137.7M 120.2M 102.9M 92.1M
Cost of revenue 23.9M 16.1M 13.2M 13.1M
Gross profit 113.8M 104.1M 89.7M 79.0M
Operating expense
Research & development 34.8M 27.1M 39.5M 20.3M
Selling general and admin 54.0M 47.3M 42.9M 33.2M
Other operating expenses
Operating income 25.0M 29.7M 7.3M 25.5M
Non operating interest income
Income
Expense 5.7M 5.7M 5.8M 6.0M
Other income expense 2.8M 2.4M 3.1M 2.2M
Pretax income 22.1M 26.3M 4.7M 21.7M
Tax provision -310.9M 2.3M 347.5K 1.8M
Net income 332.9M 24.0M 4.3M 19.9M
Basic EPS 0.2 0.0 0.2
Diluted EPS 0.2 0.0 0.2
Basic average shares 125.0M 124.9M 123.7M
Diluted average shares 138.5M 138.6M 136.5M
EBITDA 27.8M 32.1M 10.5M 27.7M
Net income from continuing op. 332.9M 24.0M 4.3M 19.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 49 minutes

10:10
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).